Table 7 Comparison of general information and gene expressions between patients with and without gastrointestinal bleeding

Gender[cases (%)]

 Male

8(66.67)

8(61.54)

0.071

0.790

 Female

4(33.33)

5(38.46)

Age (\(\overline{x} \pm {\text{s}}\), years old)

69.17 ± 5.42

70.62 ± 3.69

0.787

0.440

Smoking history[cases (%)]

1.629

0.117

 Yes

5(41.67)

6(46.15)

0.051

0.821

 No

7(58.33)

7(53.85)

Systolic pressures (\(\overline{x} \pm {\text{s}}\), mmHg)

180.83 ± 8.10

173.85 ± 12.64

1.629

0.117

Diastolic pressures (\(\overline{x} \pm {\text{s}}\), mmHg)

101.00 ± 14.08

98.31 ± 12.30

0.510

0.615

Diabetes[cases (%)]

8(66.67)

5(38.46)

1.989

0.158

Hyperlipidemia[cases (%)]

5(41.67)

6(46.15)

0.051

0.821

Coronary heart disease[cases (%)]

1(8.33)

2(15.38)

0.294

0.588

Hypertension course (\(\overline{x} \pm {\text{s}}\), years)

11.33 ± 2.74

12.38 ± 3.36

0.853

0.402

Cerebral hemorrhage volume (\(\overline{x} \pm {\text{s}}\), ml)

53.38 ± 10.34

42.00 ± 9.29

2.886

0.008

Gene expressions

 SPI1

0.64 ± 0.11

0.63 ± 0.08

0.263

0.795

 HK3

1.47 ± 0.30

1.49 ± 0.22

0.188

0.852

 HCK

 1.44 ± 0.23

1.48 ± 0.14

0.527

0.603

 SYK

1.49 ± 0.19

1.47 ± 0.16

0.271

0.789

 CD14

1.46 ± 0.21

1.49 ± 0.17

0.389

0.701

 FCER1G

1.69 ± 0.20

1.65 ± 0.16

0.521

0.607

 CYBB

1.44 ± 0.23

1.41 ± 0.19

0.322

0.750

 FGR

1.55 ± 0.23

1.56 ± 0.16

0.091

0.928